ClassID:

94077

C07D207/36 - CPC Classification

Classification description:

Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms Oxygen or sulfur atoms

Sub-classes:
Recent Application in this class:
#1
20260000642
2026-01-01

PYRROLES AND IMIDAZOLES AS BET PROTEIN INHIBITORS

#2
20250376443
2025-12-11

MASP-2 INHIBITORS AND METHODS OF USE

#3
20250368604
2025-12-04

MASP-2 INHIBITORS AND METHODS OF USE

#4
20250263370
2025-08-21

PYRROLES AND IMIDAZOLES AS BET PROTEIN INHIBITORS

#5
20250188039
2025-06-12

HYDANTOIN CONTAINING DEOXYURIDINE TRIPHOSPHATASE INHIBITORS

#6
20250129020
2025-04-24

MASP-2 INHIBITORS AND METHODS OF USE

#7
20240391886
2024-11-28

CARBON MONOXIDE PRODRUGS FOR THE TREATMENT OF MEDICAL DISORDERS

#8
20240360115
2024-10-31

COMPOSITIONS AND METHODS FOR VIRAL SENSITIZATION

#9
20240336567
2024-10-10

PESTICIDAL AND HERBICIDAL COMPOUNDS AND METHODS OF USE THEREOF

#10
20240299385
2024-09-12

3-PYRROLYLSULFONAMIDE COMPOUNDS AS GPR17 ANTAGONISTS

#11
20230406821
2023-12-21

STRIGOLACTONE DERIVATIVES

#12
20230322669
2023-10-12

Method for producing pyrrole compound

#13
20230145071
2023-05-11

MASP-2 inhibitors and methods of use

#14
20230126280
2023-04-27

Hydantoin containing deoxyuridine triphosphatase inhibitors

#15
20230088365
2023-03-23

PROCESS FOR PRODUCING PYRROLE COMPOUND

#16
20230060011
2023-02-23

Antibacterial compounds

#17
20230012560
2023-01-19

HEPATITIS B ANTIVIRAL AGENTS

#18
20220402879
2022-12-22

Hydantoin containing deoxyuridine triphosphatase inhibitors

#19
20220380384
2022-12-01

INTERNAL CYCLIC SULPHIAMIDINE AMIDE-ARYL AMIDE COMPOUND AND USE THEREOF FOR TREATING HEPATITIS B

#20
20220267260
2022-08-25

COMPOUNDS CONTAINING A SULFONIC GROUP AS KAT INHIBITORS

#21
20220259146
2022-08-18

METHOD FOR PREPARING INTERMEDIATE OF 4-METHOXYPYRROLE DERIVATIVE

#22
20220220101
2022-07-14

Compositions and methods for viral sensitization

#23
20220017486
2022-01-20

DOCK1-INHIBITING COMPOUND AND USE THEREOF

#24
20220009952
2022-01-13

Process for preparing sulfonamide compounds

#25
20210309609
2021-10-07

Method for producing pyrrole compound

#26
20210300867
2021-09-30

SELF-STABILIZING LINKER CONJUGATES

#27
20210284606
2021-09-16

TETRALIN AND INDANE DERIVATIVES AND USES THEREOF

#28
20210238155
2021-08-05

Carbon monoxide prodrugs for the treatment of medical disorders

#29
20210236463
2021-08-05

β-lactamase inhibitor

#30
20210230115
2021-07-29

Antibacterial compounds

#31
20210221788
2021-07-22

Method for preparing sulfonamides drugs

#32
20210122710
2021-04-29

Phenylamine compounds

#33
20210114981
2021-04-22

Elimination of hepatitis b virus with antiviral agents

#34
20210070705
2021-03-11

Process for producing pyrrole compound

#35
20210024462
2021-01-28

SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

#36
20200399216
2020-12-24

Endocyclic thiamidinoamide-arylamide compound and use thereof for treating hepatitis B

#37
20200361868
2020-11-19

4-OXO-alkylated tetramic acid compound, preparation method and use thereof

#38
20200354351
2020-11-12

Compositions and methods for viral sensitization

#39
20200354316
2020-11-12

Strigolactone derivauves

#40
20200255385
2020-08-13

Hydantoin containing deoxyuridine triphosphatase inhibitors

#41
20200255373
2020-08-13

SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

#42
20200181080
2020-06-11

Method for preparing intermediate of 4-methoxypyrrole derivative

#43
20200181079
2020-06-11

Method for preparing intermediate of 4-methoxypyrrole derivative

#44
20200148637
2020-05-14

Method for producing pyrrole compound

#45
20200115336
2020-04-16

Process for producing pyrrole compound

#46
20200115333
2020-04-16

TETRALIN AND INDANE DERIVATIVES AND USES THEREOF

#47
20200039931
2020-02-06

SULPHAMOYLPYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

#48
20190367452
2019-12-05

MASP-2 inhibitors and methods of use

#49
20190308927
2019-10-10

Process and intermediates

#50
20190241514
2019-08-08

Elimination of hepatitis B virus with antiviral agents

#51
20190194163
2019-06-27

Dual NAV1.2/5HT2a inhibitors for treating CNS disorders

#52
20190127324
2019-05-02

5-aryl-1H-pyrrole-3-carbonitrile and a pharmaceutical product using the same

#53
20190119207
2019-04-25

Prodigiosin analogs

#54
20180354889
2018-12-13

Process and intermediates

#55
20180319743
2018-11-08

TETRALIN AND INDANE DERIVATIVES AND USES THEREOF

#56
20180265467
2018-09-20

PYRAZOLIDINE DERIVATIVES AND RELATED COMPOUNDS

#57
20180194736
2018-07-12

Hydantoin containing deoxyuridine triphosphatase inhibitors

#58
20180186737
2018-07-05

Hydantoin containing deoxyuridine triphosphatase inhibitors

#59
20180186736
2018-07-05

Method for producing pyrrole compound

#60
20180154011
2018-06-07

SELF-STABILIZING LINKER CONJUGATES

#61
20180141905
2018-05-24

Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B

#62
20180127361
2018-05-10

Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B

#63
20180118700
2018-05-03

Piperazine and piperidine derivatives, their synthesis and use thereof in inhibiting VDAC oligomerization, apoptosis and mitochondria dysfunction

#64
20180118679
2018-05-03

N-methyl pyrazoles

#65
20180112190
2018-04-26

Compositions and methods for viral sensitization

#66
20180093950
2018-04-05

Ribociclib intermediate and preparation method therefor

#67
20180009746
2018-01-11

5-aryl-1H-pyrrole-3-carbonitrile and a pharmaceutical product using the same

#68
20170369474
2017-12-28

COMPOUNDS, COMPOSITIONS AND METHODS OF USE

#69
20170247321
2017-08-31

TETRALIN AND INDANE DERIVATIVES AND USES THEREOF

#70
20170183333
2017-06-29

DERIVATIVES OF N-(ARYLAMINO) SULFONAMIDES AS INHIBITORS OF MEK

#71
20170088515
2017-03-30

IDENTIFICATION OF COMPOUNDS THAT DISPERSE TDP-43 INCLUSIONS

#72
20160368900
2016-12-22

Plant growth regulating compounds

#73
20160297757
2016-10-13

Polysubstituted pyrroles having microtubule-disrupting, cytotoxic and antitumor activities and methods of use thereof

#74
20160219881
2016-08-04

HERBICIDALLY ACTIVE 2-HALOGEN-4-ALKYNYL-PHENYL-PYRAZOLIDINE-DIONE OR PYRROLIDINE-DIONE DERIVATIVES

#75
20160130224
2016-05-12

Novel Pyrrole Derivatives

#76
20160120864
2016-05-05

Novel Pyrrole Derivatives

#77
20160115125
2016-04-28

Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B

#78
20160060217
2016-03-03

Intermediates for producing NEP inhibitors or prodrugs thereof

#79
20160046576
2016-02-18

NOVEL PYRROLE DERIVATIVES

#80
20160009623
2016-01-14

Lipophilic curcumin analogs and methods of inhibiting HIV-1, treating latent HIV in the brain, and preventing HIV-mediated cognitive decline and HIV dementia

#81
20160002187
2016-01-07

Apoptosis-inducing agent for the treatment of cancer and immune and autoimmune diseases

#82
20150320879
2015-11-12

SELF-STABILIZING LINKER CONJUGATES

#83
20150274733
2015-10-01

Substituted pyrrolo[3,4-d]pyrimidines as kinase inhibitors

#84
20150266890
2015-09-24

Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B

#85
20150266817
2015-09-24

Tetralin and indane derivatives and uses thereof

#86
20150240006
2015-08-27

Solid-phase supports and uses thereof

#87
20150191435
2015-07-09

Dual-acting imidazole antihypertensive agents

#88
20150175541
2015-06-25

Partially saturated nitrogen-containing heterocyclic compound

#89
20150065543
2015-03-05

Dual-acting antihypertensive agents

#90
20150065534
2015-03-05

Integrin antagonist conjugates for targeted delivery to cells expressing LFA-1

#91
20150025042
2015-01-22

Compounds for treating proliferative disorders

#92
20140371468
2014-12-18

Process for the preparation of 1-H-pyrrolidine-2,4-dione derivatives

#93
20140309193
2014-10-16

Pyrrole derivatives

#94
20140303378
2014-10-09

Process for producing pyrrole compound

#95
20140303222
2014-10-09

Dual-acting imidazole antihypertensive agents

#96
20140275079
2014-09-18

Pyrrole-3-carboxamide bromodomain inhibitors

#97
20140243546
2014-08-28

Processes for producing NEP inhibitors or prodrugs thereof

#98
20140142082
2014-05-22

Pyrrolo sulfonamide compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-γ (ROR-γ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases

#99
20140080780
2014-03-20

Identification of compounds that disperse TDP-43 inclusions

#100
20140051742
2014-02-20

Lipophilic curcumin analogs and methods of inhibiting HIV-1, treating latent HIV in the brain, and preventing HIV-mediated cognitive decline and HIV dementia

#101
20140031331
2014-01-30

Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy

#102
20130338313
2013-12-19

Amide-extended crosslinking compounds and methods for use thereof

#103
20130317074
2013-11-28

Topical antifungal agent

#104
20130309256
2013-11-21

Self-stabilizing linker conjugates

#105
20130225619
2013-08-29

Substituted heterocyclic compounds for disease treatment

#106
20130190377
2013-07-25

Lactams

#107
20130184472
2013-07-18

Process for the preparation of 1-aryl-pyrazol-3-one intermediates useful in the synthesis of sigma receptors inhibitors

#108
20130184278
2013-07-18

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

#109
20130184238
2013-07-18

Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy

#110
20130178636
2013-07-11

ESTERS OF HEXANOIC ACIDS AS INTERMEDIATES FOR THE PREPARATION OF ATORVASTATIN

#111
20130172576
2013-07-04

Branched hetero polyfunctional polyoxyalkylene compound and intermediate thereof

#112
20130116249
2013-05-09

Indolizine derivatives, process for the preparation thereof and therapeutic use thereof

#113
20120264752
2012-10-18

Dual-acting antihypertensive agents

#114
20120209009
2012-08-16

Synthetic route to ABCD-porphyrins

#115
20120190865
2012-07-26

Process for the preparation of 1-H-pyrrolidine-2,4-dione derivatives

#116
20120178927
2012-07-12

Cycloalkylphenyl substituted cyclic ketoenols

#117
20120165381
2012-06-28

Dual-acting imidazole antihypertensive agents

#118
20120122780
2012-05-17

Compounds, Compositions and Methods for Modulating Uric Acid Levels

#119
20120095012
2012-04-19

TOLUIDINE SULFONAMIDES AND THEIR USE

#120
20120088837
2012-04-12

Tetralin and indane derivatives and uses thereof

#121
20120053192
2012-03-01

Heterocyclic substituted acardite derivate and application thereof

#122
20120045720
2012-02-23

Developers and method of coloring lithographic printing members

#123
20120022076
2012-01-26

Derivatives of N-(arylamino)sulfonamides as inhibitors of MEK

#124
20110306774
2011-12-15

Synthetic route to ABCD-porphyrins

#125
20110306769
2011-12-15

Process for producing pyrrole compound

#126
20110306646
2011-12-15

Fungicidal N-(Phenylcycloalkyl)carboxamide, N-(Benzylcycloalkyl)carboxamide and thiocarboxamide derivatives

#127
20110288040
2011-11-24

Aryl- or heteroaryl-sulfonyl compounds as acid secretion inhibitors

#128
20110281925
2011-11-17

Dual-acting antihypertensive agents

#129
20110275669
2011-11-10

Pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine

#130
20110251388
2011-10-13

1-heterodiene derivative and harmful organism control agent

#131
20110230346
2011-09-22

Biphenyl-substituted cyclic ketoenols

#132
20110213160
2011-09-01

2,4,6-Phenyl-Substituted Derivatives

#133
20110195842
2011-08-11

2,4,6-Phenyl-Substituted Cyclic Ketoenols

#134
20110178108
2011-07-21

Group of amino substituted benzoyl derivatives and their preparation and their use

#135
20110178091
2011-07-21

Arylpiperazine-containing pyrrole 3-carboxamide derivatives for treating depressive disorders

#136
20110152466
2011-06-23

Amide-extended crosslinking compounds and methods for use thereof

#137
20110092551
2011-04-21

Dual-acting imidazole antihypertensive agents

#138
20110082183
2011-04-07

Phenyl pyrrole aminoguanidine derivatives

#139
20110046397
2011-02-24

Processes

#140
20110040103
2011-02-17

Preparation of pentafluorosulfanyl (SF) heterocycles: pyrroles and thiophenes

#141
20100298299
2010-11-25

NON-PEPTIDE DERIVATIVES AS BRADYKININ B1 ANTAGONISTS

#142
20100273739
2010-10-28

Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy

#143
20100267132
2010-10-21

In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells

#144
20100261934
2010-10-14

Method for preparing 2,6-diethyl-4-methylphenylacetic acid

#145
20100240661
2010-09-23

Azabicyclo [3. 1. 0] hexyl derivatives as modulators of dopamine Dreceptors

#146
20100197668
2010-08-05

1,2,3,4-TETRAHYDROPYRROLO[1,2-A]PYRAZINE-6-CARBOXAMIDE AND 2,3,4,5-TETRAHYDROPYRROLO[1,2-a][1,4]-DIAZEPINE-7-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF

#147
20100184766
2010-07-22

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

#148
20100130742
2010-05-27

Tetralin and indane derivatives and uses thereof

#149
20100113421
2010-05-06

NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS

#150
20100099874
2010-04-22

Transannular rearrangement of activated lactams

#151
20100081635
2010-04-01

Compounds for treating proliferative disorders

#152
20100022615
2010-01-28

Activated cytotoxic compounds for attachment to targeting molecules for the treatment of mammalian disease conditions

#153
20100009850
2010-01-14

Iodine-phenyl-substituted cyclic cetoenols

#154
20090305891
2009-12-10

Cycloalkylphenyl substituted cyclic ketoenols

#155
20090298828
2009-12-03

Alkoxyalkyl-substituted cyclic keto-enols

#156
20090292000
2009-11-26

Pyrrolidine derivatives as prostaglandin modulators

#157
20090239906
2009-09-24

Alkoxyalkyl-substituted cyclic ketoenols

#158
20090118335
2009-05-07

Aryl-or heteroaryl-sulfonyl compounds as acid secretion inhibitors

#159
20090082576
2009-03-26

Synthetic route to ABCD-porphyrins

#160
20090082457
2009-03-26

Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK

#161
20090023228
2009-01-22

Dual-acting imidazole antihypertensive agents

#162
20090018183
2009-01-15

N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands

#163
20080318776
2008-12-25

2,6-Diethyl-4-Methylphenyl-Substituted Tetramic Acid Derivatives

#164
20080293751
2008-11-27

Tetralin and indane derivatives and uses thereof

#165
20080287424
2008-11-20

AZOLYLACYLGUANIDINES AS beta-SECRETASE INHIBITORS

#166
20080269305
2008-10-30

Dual-acting antihypertensive agents

#167
20080188402
2008-08-07

Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine

#168
20080182333
2008-07-31

Fluorescent chemosensors for metals based on dipyrrins

#169
20080167361
2008-07-10

Arylsulfonyl pyrrolidines as 5-HTinhibitors

#170
20080114051
2008-05-15

Pyrrolidine derivatives as prostaglandin modulators

#171
20080058340
2008-03-06

Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK

#172
20080015256
2008-01-17

Tetralin and indane derivatives and uses thereof

#173
20070298968
2007-12-27

2,4,6-phenyl-substituted cyclic ketoenols

#174
20070281976
2007-12-06

Pesticidal agents on the basis of 1-aryl-aminopyrrol

#175
20070248594
2007-10-25

CXCR1 AND CXCR2 CHEMOKINE ANTAGONISTS

#176
20070238776
2007-10-11

Pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine

#177
20070066573
2007-03-22

Pyrrole and pyrazole derivatives as potentiators of glutamate receptors

#178
20060287378
2006-12-21

Novel pyrroles and imidazoles

#179
20060205732
2006-09-14

Heterocyclic carboxamides and their use as fungicides

#180
20060183790
2006-08-17

Azolylacylguanidines as β-secretase inhibitors

#181
20060167255
2006-07-27

Tetralin and indane derivatives and uses thereof

#182
20060148798
2006-07-06

N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands

#183
20060094773
2006-05-04

3-Phenyl substituted 3-substituted-4ketolactams and ketolactones

#184
20060014794
2006-01-19

CXCR1 and CXCR2 chemokine antagonists

#185
20050239857
2005-10-27

Novel imidazoles

#186
20050215548
2005-09-29

Bisarylsulfonamide compounds and their use in cancer therapy

#187
20050176800
2005-08-11

Pyrrolidine derivatives as prostaglandin modulators

#188
20050049292
2005-03-03

Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression

#189
20050043546
2005-02-24

Processes for the production of amino-protected derivatives of 4-aminomethylene-pyrrolidin-3-one and/or 4-aminomethylene-pyrrolidin-3-alkoxyimino derivatives and/or gemifloxacin or a salt thereof

#190
20050043364
2005-02-24

Pyrrole-based HMG-CoA reductase inhibitors

#191
20050038242
2005-02-17

Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action

#192
20050026991
2005-02-03

Derivatives of 3-hydroxy-pyrrole-2,4-dicarboxylic acid and uses thereof

#193
20050004371
2005-01-06

Solution and solid phase synthesis of pyrrolinones and polypyrrolinones

#194
20050004180
2005-01-06

Pyrrolidinone derivatives